Reports Outline Human Papillomavirus Study Findings from Department of Obstetrics and Gynecology (Treatment with Epigallocatechin Gallate, Folic Acid, Vitamin B12, and Hyaluronic Acid Decreases HPV Positivity in Women Attending Regional...).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      A recent study conducted by the Department of Obstetrics and Gynecology has found that a combination of epigallocatechin gallate (EGCG), folic acid (FA), vitamin B12, and hyaluronic acid (HA) can decrease human papillomavirus (HPV) positivity in women. The study enrolled 163 women with a positive HPV DNA test or previous history of HPV infections, and the treatment group received the oral combination for three months. The treatment group experienced a significant reduction in HPV positivity and an improvement in cervical lesions compared to the control group. This research provides insight into potential innovative therapies for HPV. [Extracted from the article]
    • Abstract:
      Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)